Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Inflammatory Bowel Diseases × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammatory Bowel Diseases 1

Interventions

Standard of Care 1 Passive Cutaneous Anaphylaxis 1 Oxygen 1 Morphine 1 Infliximab 1 Anesthesia, Spinal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06109961 2023-11-07

HYPNOTIC

Ottawa Hospital Research Institute

Phase 1/2 Unknown

Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡